Mallinckrodt plc (MNK) CEO Mark Trudeau on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/04/20
Mallinckrodt stock plunges after talks regarding possible bankruptcy filing, offsetting adjusted profit beatMarket Watch • 08/04/20
Mallinckrodt beats adjusted profit expectations, is in talks regarding possible bankruptcy filingMarket Watch • 08/04/20
Mallinckrodt plc Reports Earnings for the Second Quarter 2020 and Highlights Pipeline AdvancementsPRNewsWire • 08/04/20
Earnings Preview: Mallinckrodt (MNK) Q2 Earnings Expected to DeclineZacks Investment Research • 07/28/20
Are Options Traders Betting on a Big Move in Cameco Mallinckrodt (MNK) Stock?Zacks Investment Research • 07/20/20
Mallinckrodt Announces U.S. Food and Drug Administration (FDA) Advisory Committee Voted to Recommend Terlipressin for Approval to Treat Patients with Hepatorenal Syndrome Type 1 (HRS-1)PRNewsWire • 07/15/20
Mallinckrodt to Present Phase 3 StrataGraft® Regenerative Skin Tissue Clinical Trial Results on Severe Burns During the Virtual American Burn Association 52nd Annual MeetingPRNewsWire • 06/15/20
Real-World Data of Terlipressin in Hospitalized Patients in U.K. with Hepatorenal Syndrome Type 1 (HRS-1) Published in Alimentary Pharmacology and TherapeuticsPRNewsWire • 06/11/20
Mallinckrodt Completes Rolling Submission of Biologics License Application for StrataGraft® Regenerative Skin Tissue to U.S. Food and Drug AdministrationPRNewsWire • 06/09/20
Mallinckrodt Will Appeal District Court Ruling in Case Involving Ongoing Acthar Medicaid Drug Rebate Dispute with the Centers for Medicare and Medicaid Services (CMS)PRNewsWire • 06/01/20
Mallinckrodt's stock sinks after J.P. Morgan turns bearish, after long run of being neutralMarket Watch • 05/19/20